Hepatitis C virus (HCV), a non-cytopathic positive-stranded RNA virus, is one of the most
common causes of chronic liver diseases such as chronic hepatitis, liver cirrhosis and …

Background A novel dinucleotide variant TT/∆ G (ss469415590) has been associated with
hepatitis C virus clearance. Aim To assess the role of the ss469415590 variant, compared …

In a recent expert meeting, Swedish recommendations for the treatment of HCV infection
were upgraded. The panel recommends vaccination against both hepatitis A and B in …

Hepatitis C virus (HCV) infection is a major cause of chronic liver disease and associated
complications such as liver cirrhosis and hepatocellular carcinoma. Interferons (IFNs) are …

Direct-acting antiviral (DAA) therapies have revolutionised the treatment of hepatitis C virus
(HCV). The financial cost of DAAs however is significant, and first generation protease …

Although not directly cytopathic, hepatitis B and C viruses (HBV and HCV) are responsible
for millions of deaths per year, and the aging patient population presents a severe public …

The role of chemokines in chronic hepatitis C virus (HCV) infection is not fully understood.
The present study aimed to characterize the baseline serum concentrations and the initial β …

BACKGROUND: No study evaluates serum levels of CXCL10 and CCL2 chemokines in
patients with hepatitis C associated mixed cryoglobulinaemia. AIMS: To measure circulating …

Background: CXCR3A-associated chemokines (CXCL9-11) are implicated in the
pathogenesis of hepatitis C virus (HCV) infection. We analyzed the association between …

The influenza A H7N9 virus outbreak in Eastern China in the spring of 2013 represented a
novel, emerging avian influenza transmission to humans. While clinical and microbiological …